Last week, we proudly announced the ninth cohort of our Hardware Catalyst Initiative Canada’s only hardware and silicon-focused incubator helping deep tech ventures accelerate from lab to market.
This cohort features 26 incredible companies building technologies that will shape a smarter, safer, and more connected world. Today, we’re spotlighting the game-changers in the MedTech and Mobility sectors, two sectors where hardware innovation is not just advancing, it’s transforming lives and entire industries.
Hardware and AI-driven solutions driving the future of transportation, mobility, and space systems:
AWOS Technologies is a Canadian automotive safety technology company pioneering vehicle egress innovation. AWOS is designed to prevent occupant entrapment in water and fire emergencies, a common but unaddressed global safety issue responsible for thousands of preventable fatalities each year. Its flagship product, the Automatic Window Opening System (AWOS), uses proprietary sensor technology to automatically lower power windows in emergencies—such as submersion or fire—enabling rapid escape and triggering emergency response.
Torabix Inc. is an innovative automotive safety startup, focused on developing patented hardware solutions to prevent accidents caused by tire blowouts, significantly enhancing vehicle safety and saving lives. Their technology is the only solution in the market that ensures vehicle control during tire failures by mitigating torque, distributing forces, and maintaining steering control.
Moon Trades builds AI-powered autonomous robotic systems that revolutionize mineral exploration through non-invasive, environmentally sustainable methods. Their platforms use geospatial data to identify high-probability drilling targets, reducing exploration costs and boosting success rates while minimizing environmental impact in natural resource extraction.
NordSpace is an end-to-end space systems manufacturing company that brings launch vehicles and custom satellite space systems to solve customers' needs in space. This includes earth observation, environmental & climate change monitoring, remote communications, and defence applications.
Heamac Inc. is focused on maternal and neonatal healthcare. Heamac’s flagship product, the nLite360, is an advanced phototherapy device designed to treat severe jaundice in newborns. Through a combination of patented technologies, data-driven care, and service models, Heamac is redefining the standard of care for newborns—particularly in critical and underserved settings.
Headsense is developing an advanced sensor and AI-driven system designed to monitor head position, visual scanning, and cognitive load in real time. It is built for athletes, military personnel, and tactical operators who rely on rapid decision-making and situational awareness. By providing real-time feedback and predictive analytics, the technology helps reduce the risk of traumatic brain injuries, enhance performance, and improve safety. Combining wearable sensors, machine learning, and data fusion, their solution empowers users with actionable insights to optimize training, prevent injuries, and extend career longevity in high-impact environments.
Imagine a world where health insights are as accessible as the air we breathe—where respiratory data and AI-enabled analytics empower individuals, industries, and governments to make better decisions. Healthmetryx is at the forefront of this transformation, pioneering technologies that collect and analyze respiratory data for health insights.
Its patent-pending wearable Clarinet device along with the AI-enabled Respiratory Cloud Machine collect and analyze breath data, offering unprecedented data visibility for applications in population health, clinical research, and workforce wellness. With partnerships with industry giants like NASA, Amazon, NVIDIA, and Samsung, Healthmetryx stands as a visionary leader in AI-enabled respiratory analytics.
Sci-Bots is a pioneer in digital microfluidics technology, empowering researchers and innovators with precise and flexible solutions for automated lab-on-a-chip applications. Sci-Bots seeks to streamline complex biochemical processes, enhancing reproducibility, scalability, and efficiency in laboratories worldwide.
DIA Labs Canada is a Mississauga-based medical device R&D company developing Class II novel device designed for continuous asthma monitoring through the interstitial fluid (ISF) called AirSense.
AirSense offers a real-time monitoring solution for both asthma patients and drug sponsors, supporting more effective disease management and clinical research.
Patients 66 years and older in the ICU on a breathing machine for 2 weeks or longer, have only a 50% chance they will bathe, or dress independently, ever again. Within days of being admitted to the ICU, their muscles weaken and begin to waste, a condition known as ICU-Acquired Weakness (ICUAW).
Elaya develops custom hardware and software solutions that enable neuromuscular electrical stimulation therapy in the ICU to prevent ICUAW, improve patient outcomes and post-ICU quality of life.